1887
Research Open Access
Like 2

Abstract

Introduction: Since 2015, increased migration from Asia and Africa to Europe has raised public health concerns about potential importation of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE), specifically those producing carbapenemases (C-PE), into European hospitals.

Aims: To inform infection control practices about ESBL-PE prevalence in asylum seekers and to investigate whether C-PE prevalence exceeds that in the German population.

Methods: Cross-sectional study from April 2016–March 2017. Routinely collected stool samples from asylum seekers were tested for antibiotic resistant Enterobacteriaceae. Country/region of origin and demographic characteristics were explored as risk factors for faecal colonisation.

Results: Of 1,544 individuals, 294 tested positive for ESBL-PE colonisation (19.0%; 95% confidence intervals (CI): 17.0–21.0). Asylum seekers originating from Afghanistan/Pakistan/Iran had a prevalence of 29.3% (95% CI: 25.6–33.2), from Syria 20.4% (95% CI: 16.1–25.2) and from Eritrea/Somalia 11.9% (95% CI: 8.7–15.7). CTX-M-15 (79%) and CTX-M-27 (10%) were the most common ESBL determinants. Highest ESBL-PE prevalences were observed in boys under 10 years and women aged 20–39 years (interaction: p = 0.03). No individuals tested positive for C-PE. Faecal C-PE colonisation prevalence in asylum seekers was not statistically significantly different from prevalence reported in German communities.

Conclusion: In absence of other risk factors, being a newly arrived asylum seeker from a region with increased faecal ESBL-PE colonisation prevalence is not an indicator for C-PE colonisation and thus not a reason for pre-emptive screening and isolation upon hospital admission.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.8.1800030
2019-02-21
2019-08-23
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.8.1800030
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/8/eurosurv-24-8-7.html?itemId=/content/10.2807/1560-7917.ES.2019.24.8.1800030&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Antimicrobial Resistance. Global Report on surveillance. Geneva: WHO; 2014.Available from: https://www.who.int/drugresistance/documents/surveillancereport/en/
  2. Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176-87.  https://doi.org/10.1016/S0140-6736(15)00473-0  PMID: 26603922 
  3. Arcilla MS, van Hattem JM, Haverkate MR, Bootsma MCJ, van Genderen PJJ, Goorhuis A, et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17(1):78-85.  https://doi.org/10.1016/S1473-3099(16)30319-X  PMID: 27751772 
  4. Hassing RJ, Alsma J, Arcilla MS, van Genderen PJ, Stricker BH, Verbon A. International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review. Euro Surveill. 2015;20(47):30074. PMID: 26625301 
  5. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect. 2008;57(6):441-8.  https://doi.org/10.1016/j.jinf.2008.09.034  PMID: 18990451 
  6. Campos AC, Albiero J, Ecker AB, Kuroda CM, Meirelles LE, Polato A, et al. Outbreak of Klebsiella pneumoniae carbapenemase-producing K pneumoniae: A systematic review. Am J Infect Control. 2016;44(11):1374-80.  https://doi.org/10.1016/j.ajic.2016.03.022  PMID: 27156198 
  7. Desta K, Woldeamanuel Y, Azazh A, Mohammod H, Desalegn D, Shimelis D, et al. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia. PLoS One. 2016;11(8):e0161685.  https://doi.org/10.1371/journal.pone.0161685  PMID: 27574974 
  8. Lohr B, Pfeifer Y, Heudorf U, Rangger C, Norris DE, Hunfeld KP. High Prevalence of Multidrug-Resistant Bacteria in Libyan War Casualties Admitted to a Tertiary Care Hospital, Germany. Microb Drug Resist. 2018;24(5):578-84.  https://doi.org/10.1089/mdr.2017.0141  PMID: 29039717 
  9. Ravensbergen SJ, Berends M, Stienstra Y, Ott A. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands. PLoS One. 2017;12(4):e0176481.  https://doi.org/10.1371/journal.pone.0176481  PMID: 28441421 
  10. Reinheimer C, Kempf VA, Göttig S, Hogardt M, Wichelhaus TA, O’Rourke F, et al. Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June‒December 2015. Euro Surveill. 2016;21(2):30110.  https://doi.org/10.2807/1560-7917.ES.2016.21.2.30110  PMID: 26794850 
  11. Heudorf U, Krackhardt B, Karathana M, Kleinkauf N, Zinn C. Multidrug-resistant bacteria in unaccompanied refugee minors arriving in Frankfurt am Main, Germany, October to November 2015. Euro Surveill. 2016;21(2):30109.  https://doi.org/10.2807/1560-7917.ES.2016.21.2.30109  PMID: 26838714 
  12. Bertrand X, Dowzicky MJ. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Clin Ther. 2012;34(1):124-37.  https://doi.org/10.1016/j.clinthera.2011.11.023  PMID: 22154196 
  13. Walter J, Haller S, Hermes J, Arvand M, Abu Sin M, Eckmanns T. Letter to the editor: Is there a need for special treatment of refugees at hospital admission? Euro Surveill. 2016;21(7):30137.
  14. European Centre for Disease Prevention and Control (ECDC). Carbapenem-resistant Enterobacteriaceae. Stockholm: ECDC; 2016. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/carbapenem-resistant-enterobacteriaceae-risk-assessment-april-2016.pdf
  15. Ravensbergen SJ, Lokate M, Cornish D, Kloeze E, Ott A, Friedrich AW, et al. High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015. PLoS One. 2016;11(5):e0154791.  https://doi.org/10.1371/journal.pone.0154791  PMID: 27144599 
  16. Heudorf U, Albert-Braun S, Hunfeld KP, Birne FU, Schulze J, Strobel K, et al. Multidrug-resistant organisms in refugees: prevalences and impact on infection control in hospitals. GMS Hyg Infect Control. 2016;11:Doc16. PMID: 27579250 
  17. Valenza G, Nickel S, Pfeifer Y, Eller C, Krupa E, Lehner-Reindl V, et al. Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother. 2014;58(2):1228-30.  https://doi.org/10.1128/AAC.01993-13  PMID: 24295972 
  18. Ministerium für Soziales, Arbeit, Gesundheit und Demografie, Rheinland-Pfalz (MSAGD). Verwaltungsvorschrift 21260: Gesundheitsuntersuchung bei Asylbegehrenden [Administrative provision 21260: Health check for asylum seekers]. Mainz: MSAGD; 1999.German. Available from: http://landesrecht.rlp.de/jportal/?quelle=jlink&docid=VVRP000000114&psml=bsrlpprod.psml
  19. Ehlkes L, George M, Knautz D, Burckhardt F, Jahn K, Vogt M, et al. Negligible import of enteric pathogens by newly-arrived asylum seekers and no impact on incidence of notified Salmonella and Shigella infections and outbreaks in Rhineland-Palatinate, Germany, January 2015 to May 2016. Euro Surveill. 2018;23(20):17-00463.  https://doi.org/10.2807/1560-7917.ES.2018.23.20.17-00463  PMID: 29790462 
  20. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0. Växjö: EUCAST; 2016. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_6.0_Breakpoint_table.pdf
  21. Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, et al. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J Med Microbiol. 2009;58(Pt 7):912-22.  https://doi.org/10.1099/jmm.0.005850-0  PMID: 19502377 
  22. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Göttig S, Hunfeld KP, et al. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother. 2011;66(9):1998-2001.  https://doi.org/10.1093/jac/dkr256  PMID: 21693460 
  23. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006;258(1):72-7.  https://doi.org/10.1111/j.1574-6968.2006.00195.x  PMID: 16630258 
  24. Pfeifer Y, Matten J, Rabsch W. Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany. Emerg Infect Dis. 2009;15(9):1533-5.  https://doi.org/10.3201/eid1509.090567  PMID: 19788837 
  25. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother. 2006;50(11):3953-5.  https://doi.org/10.1128/AAC.00915-06  PMID: 16954321 
  26. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161-8.  https://doi.org/10.1016/S1473-3099(15)00424-7  PMID: 26603172 
  27. Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016;21(27):30280.  https://doi.org/10.2807/1560-7917.ES.2016.21.27.30280  PMID: 27416987 
  28. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66(10):4555-8.  https://doi.org/10.1128/AEM.66.10.4555-4558.2000  PMID: 11010916 
  29. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2009;63(6):1135-41.  https://doi.org/10.1093/jac/dkp122  PMID: 19351692 
  30. Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, et al. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol. 2014;52(5):1358-65.  https://doi.org/10.1128/JCM.03502-13  PMID: 24501035 
  31. United Nations. (UN) Statistics Division. Standard country or area codes for statistical use (M49). New York: UN; [assessed 11 Jun 2018]. Available from: https://unstats.un.org/unsd/methodology/m49/
  32. Harries M, Dreesman J, Rettenbacher-Riefler S, Mertens E. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and Shiga toxin-producing Escherichia coli in asymptomatic nursery children in Lower Saxony (Germany), 2014. Epidemiol Infect. 2016;144(16):3540-8.  https://doi.org/10.1017/S0950268816001837  PMID: 27608837 
  33. Valenza G, Schulze M, Friedrich P, Schneider-Brachert W, Holzmann T, Nickel S, et al. Screening of ESBL-producing Enterobacteriacae concomitant with low degree of transmission in intensive care and bone marrow transplant units. Infect Dis (Lond). 2017;49(5):405-9.  https://doi.org/10.1080/23744235.2016.1274420  PMID: 28071193 
  34. Hamprecht A, Rohde AM, Behnke M, Feihl S, Gastmeier P, Gebhardt F, et al. DZIF-ATHOS Study Group. Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. J Antimicrob Chemother. 2016;71(10):2957-63.  https://doi.org/10.1093/jac/dkw216  PMID: 27317445 
  35. Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis. Clin Infect Dis. 2016;63(3):310-8.  https://doi.org/10.1093/cid/ciw283  PMID: 27143671 
  36. Kantele A, Lääveri T, Mero S, Vilkman K, Pakkanen SH, Ollgren J, et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60(6):837-46.  https://doi.org/10.1093/cid/ciu957  PMID: 25613287 
  37. Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, et al. High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics. Clin Infect Dis. 2015;61(4):593-600.  https://doi.org/10.1093/cid/civ333  PMID: 25904368 
  38. Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S. Contact precautions for preventing nosocomial transmission of ESBL-producing Escherichia coli - a point/counterpoint review. Clin Infect Dis. 2017;65(2):342-7.  https://doi.org/10.1093/cid/cix258  PMID: 28379311 
  39. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. European Society of Clinical Microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl 1):1-55.  https://doi.org/10.1111/1469-0691.12427  PMID: 24329732 
  40. Robert Koch Institute. KRINKO: Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen [Hygiene measures for infection or colonization with multidrug-resistant gram-negative bacilli. Commission recommendation for hospital hygiene and infection prevention (KRINKO) at the Robert Koch Institute (RKI)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(10):1311-54.  https://doi.org/10.1007/s00103-012-1549-5  PMID: 23011096 
  41. Eckmanns T, Richter D, Feig M. MRSA and ESBL in outpatient: development from 2008 up to 2012 and socio demographic differences. Berl Munch Tierarztl Wochenschr. 2014;127(9-10):399-402. PMID: 25868167 
  42. Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72(8):2145-55.  https://doi.org/10.1093/jac/dkx146  PMID: 28541467 
  43. Pietsch M, Eller C, Wendt C, Holfelder M, Falgenhauer L, Fruth A, et al. RESET Study Group. Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany. Vet Microbiol. 2017;200:130-7.  https://doi.org/10.1016/j.vetmic.2015.11.028  PMID: 26654217 
  44. Dautzenberg MJ, Haverkate MR, Bonten MJ, Bootsma MC. Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis. BMJ Open. 2016;6(3):e009971.  https://doi.org/10.1136/bmjopen-2015-009971  PMID: 26988349 
  45. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66(1):1-14.  https://doi.org/10.1093/jac/dkq415  PMID: 21081548 
  46. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27(3):543-74.  https://doi.org/10.1128/CMR.00125-13  PMID: 24982321 
  47. Matsumura Y, Pitout JD, Gomi R, Matsuda T, Noguchi T, Yamamoto M, et al. Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene. Emerg Infect Dis. 2016;22(11):1900-7.  https://doi.org/10.3201/eid2211.160519  PMID: 27767006 
  48. van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother. 2012;67(9):2090-100.  https://doi.org/10.1093/jac/dks214  PMID: 22678728 
  49. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2010;35(4):316-21.  https://doi.org/10.1016/j.ijantimicag.2009.11.003  PMID: 20060273 
/content/10.2807/1560-7917.ES.2019.24.8.1800030
Loading

Data & Media loading...

Supplementary data

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error